Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias

Area of Science:

• Cardiology
• Immunology
• Genetics

Background:

• Cardiac arrhythmias cause significant morbidity and mortality.
• In 5-15% of cardiac arrest cases, no structural abnormalities are found.
• While inherited channelopathies are known, ~70% of unexplained cases remain molecularly negative.

Purpose of the Study:

• To introduce and define 'autoimmune cardiac channelopathies' as a novel mechanism for cardiac arrhythmias.
• To highlight the potential prevalence and clinical relevance of autoantibodies targeting cardiac ion channels.
• To suggest autoimmune channelopathies as a cause for unexplained arrhythmias and cardiac arrest.

Main Methods:

• Review of experimental and clinical studies on autoimmunity in cardiac arrhythmias.
• Identification of arrhythmogenic autoantibodies targeting cardiac calcium, potassium, and sodium channels.
• Analysis of autoantibody presence in patients with and without autoimmune disease.

Main Results:

• Autoantibodies targeting cardiac ion channels can induce electrophysiological changes, leading to conduction disturbances and tachyarrhythmias.
• Pathogenic autoantibodies are found in patients with overt autoimmune disease and in apparently healthy individuals.
• Autoimmune cardiac channelopathies may explain a significant proportion of unexplained arrhythmias.

Conclusions:

• Autoimmune cardiac channelopathies represent a novel and potentially frequent cause of cardiac arrhythmias.
• Detection of autoantibodies against cardiac ion channels offers new diagnostic possibilities for unexplained arrhythmias.
• Targeted testing for these autoantibodies could reveal new therapeutic strategies for patients with cardiac rhythm disturbances.